Department of Anesthesia, Schulich School of Medicine, Western University, London, ON, Canada.
Int J Obstet Anesth. 2013 Jul;22(3):188-93. doi: 10.1016/j.ijoa.2013.03.003. Epub 2013 May 3.
The analgesic benefit of TAP (transversus abdominis plane) blocks for cesarean delivery pain remains controversial. We compared the analgesic efficacy of two doses of local anesthetic for TAP blocks after cesarean delivery.
Sixty women having cesarean delivery under spinal anesthesia were randomized to receive ultrasound-guided TAP blocks using either high-dose ropivacaine (3mg/kg), low-dose ropivacaine (1.5mg/kg) or placebo. Patients received intrathecal 0.75% bupivacaine 10-12mg, fentanyl 10μg and morphine 150μg and standard multimodal analgesia. The primary outcome was the difference in pain with movement using a numeric rating scale at 24h. Other outcomes included time to first request for analgesia, pain scores at 6, 12, 36, 48h and at 6 and 12weeks, opioid consumption, adverse effects, quality of recovery, and satisfaction.
There were no differences between groups in the primary outcome. Mean ± SD pain scores (0-10) with movement at 24h were: high-dose ropivacaine 3.6±1.5, low-dose ropivacaine 4.6±2.1 and placebo 4.1±1.7. With respect to secondary outcomes, the mean ± SD pain scores at 6h were lower in the high-dose group 2.0±1.8 compared to the low-dose 3.4±2.7 and placebo groups 4.2±2.0 (P=0.009). Pain scores at 12h were also lower in the high-dose group 2.2±2.0 compared to the low-dose group 4.1±2.7 and placebo group 4.0±1.3 (P=0.011). There was no difference in other outcomes between groups.
Neither high- or low-dose TAP blocks as part of a multimodal analgesia regimen including intrathecal morphine improved pain scores with movement at 24h after cesarean delivery when compared to placebo TAP blocks. High-dose TAP blocks may improve pain scores up to 12h after cesarean delivery.
腹横肌平面(TAP)阻滞用于剖宫产术后镇痛的效果仍存在争议。我们比较了两种剂量局部麻醉药用于剖宫产术后 TAP 阻滞的镇痛效果。
60 例行椎管内麻醉剖宫产的产妇随机分为三组,接受超声引导下 TAP 阻滞,分别给予高剂量罗哌卡因(3mg/kg)、低剂量罗哌卡因(1.5mg/kg)或安慰剂。所有产妇均接受鞘内 0.75%布比卡因 10-12mg、芬太尼 10μg 和吗啡 150μg 以及标准多模式镇痛。主要结局为术后 24 小时时使用数字评分量表评估的运动时疼痛差异。其他结局包括首次镇痛需求时间、术后 6、12、36、48 小时和 6、12 周时的疼痛评分、阿片类药物用量、不良反应、恢复质量和满意度。
三组主要结局无差异。术后 24 小时运动时平均(±标准差)疼痛评分(0-10)分别为:高剂量罗哌卡因组 3.6±1.5,低剂量罗哌卡因组 4.6±2.1,安慰剂组 4.1±1.7。次要结局方面,高剂量组术后 6 小时平均(±标准差)疼痛评分 2.0±1.8 低于低剂量组 3.4±2.7 和安慰剂组 4.2±2.0(P=0.009),高剂量组术后 12 小时平均(±标准差)疼痛评分 2.2±2.0 低于低剂量组 4.1±2.7 和安慰剂组 4.0±1.3(P=0.011)。组间其他结局无差异。
与安慰剂 TAP 阻滞相比,鞘内吗啡联合 TAP 阻滞的多模式镇痛方案中,高剂量或低剂量 TAP 阻滞均不能改善剖宫产术后 24 小时的运动时疼痛评分。高剂量 TAP 阻滞可能会改善剖宫产术后 12 小时的疼痛评分。